×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Cyclacel Pharmaceuticals Shares Up 72% After Hours on Withdrawal of Offering
MarketWatch
By Josh Beckerman Cyclacel Pharmaceuticals shares rose 72% to $2.34 after hours Monday as the biopharmaceutical company withdrew a filing...
3 days ago
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced ...
Enidnews.com
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the...
10 hours ago
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?
InvestorPlace
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.
2 days ago
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future
Yahoo Finance
Cyclacel Pharmaceuticals, Inc. ( NASDAQ:CYCC ) is possibly approaching a major achievement in its business, so we would...
1 week ago
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
Seeking Alpha
Cyclacel Pharmaceuticals, Inc. (NASDAQ:NASDAQ:CYCC) Q4 2023 Earnings Call Transcript March 19, 2024 4:30 PM ETCompany ParticipantsGrace Kim...
1 month ago
$8 Million Private Placement Announcement Sends Biotech Flying
The Globe and Mail
Detailed price information for Cyclacel Pharmaceuti (CYCCP-Q) from The Globe and Mail including charting and trades.
2 days ago
Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Profit Outlook
Simply Wall Street
Consensus from 2 of the American Biotechs analysts is that Cyclacel Pharmaceuticals is on the verge of breakeven. They expect the company to...
1 month ago
CYCC Stock Quote Price and Forecast
CNN
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology...
3 months ago
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q3 2023 Earnings Call Transcript
Yahoo Finance
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Good afternoon, and welcome to the...
5 months ago
Cyclacel Pharmaceuticals names new chief medical officer
ROI-NJ
Cyclacel Pharmaceuticals, a Berkeley Heights-based biopharmaceutical company developing medicines based on cancer cell biology,...
3 months ago